The Digital Pathology Market is projected to reach $1.86 billion by 2030, at a CAGR of 8.7% from 2023 to 2030. Digital pathology involves interpreting and managing pathology information generated from digitized glass slides. The use of digital pathology has been one of the mainstream options for routine diagnostics and drug development. The use of digital pathology has increased due to its wide benefits, including sharing video streams and digital images in real time. Additionally, with the use of machine learning (ML), the assessment of images can be done beyond traditional histopathology by linking AI with clinical data.
Furthermore, the rising adoption of digital pathology has led to the emergence of virtual pathology, creating new opportunities for teleconsulting. Moreover, computer-aided diagnosis by digital images produces more precise and accurate results than a traditional microscope offering. The technology is gaining prominence due to growing requirements in anatomical pathology applications for quantitative image analysis. These emerging imaging tools enable pathologists to conduct more consistent and accurate diagnoses.
Digital pathology involves managing, acquiring, interpreting, and sharing pathology information, including data and slides, in a digital environment. These slides are created by capturing glass slides with a scanning device to provide high-resolution digital images, which can be viewed on mobile devices or computer screens.
Digital pathology improves the analysis of slides more quickly and accurately than microscopy, allowing long-term data storage for predictive analysis, providing rapid access to prior cases, and reducing errors by eliminating breakages of slides. Digital pathology also involves barcoding slides which reduce misidentification. Furthermore, it enables multiple-angle and live zoomed viewing, measuring multiple automated optical inspection (AOI), and provides a dashboard for analyzing annotations and data. Additionally, digital pathology fosters collaboration, curbs outsourcing trends, makes remote access possible with flexible work schedules, provides faster access to digital slides, reduces data organizing, matching, and retrieving time, speeds access to samples, and improves turnaround time, especially in complex cases.
Major market players are launching advanced products for use in various pathology procedures. For instance, in December 2022, Deciphex Limited (Ireland) launched its Patholytix 3.0., a digital research pathology platform. This platform allows users to effectively manage data and samples, thus overcoming the limitations of laboratory information management system (LIMS) software.
The key players operating in the digital pathology market are 3DHISTECH Ltd. (Hungary), Leica Microsystems (a subsidiary of Danaher Corporation) (Germany), Hamamatsu Photonics K.K. (Japan), Nikon Corporation (Japan), Visiopharm A/S (Denmark), Koninklijke Philips N.V. (Netherlands), F. Hoffmann-La Roche Ltd (Switzerland), Glencoe Software, Inc. (U.S.), XIFIN, Inc. (U.S.), and PerkinElmer Inc. (U.S.).
Download Free Sample Report Here : https://www.meticulousresearch.com/download-sample-report/cp_id=5433
Key questions answered in the report:
- Which are the high-growth market segments in terms of offering, application, end user, and region/country?
- What was the historical market for digital pathology across the globe?
- What are the market forecasts and estimates for the period 2023–2030?
- What are the major drivers, restraints, challenges, opportunities, and trends in the global digital pathology market?
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research